Springer Nature has acquired full ownership of the prestigious British Journal of Cancer (BJC).
Launched in 1947 as a general oncology journal, BJC publishes across the full spectrum of cancer research, covering molecular cell biology, genetics, translational research, clinical studies and epidemiology. Since the 1980s it has been published in partnership with Springer Nature.
Along with its nearly 75 years of heritage and association with CRUK, the acquisition of BJC to full ownership by Springer Nature marks an important step in the journal’s development and growth. Now as part of the wider Springer Nature oncology portfolio and medical titles, the journal will benefit from enhanced international reach, author services and international collaboration, further cementing its status as a key journal for the cancer community.
As part of this acquisition, the strong relationship between CRUK and Springer Nature will still continue. The CRUK name will still be used in relation to the journal, and the journal will continue to be published with a by-line indicating this affiliation. BJC remains a key journal for CRUK’s outreach to its research community.
Click here to read the original press release.
